Saphnelo

News

AZ's bid for Fasenra approval in COPD falls short

AstraZeneca has abandoned Fasenra development in COPD, but there is better news for the company with a new version of lupus drug Saphnelo.

News

AZ's lupus drug Saphnelo cleared in EU, challenging GSK's Be...

AstraZeneca's Saphnelo has become the first new drug to be approved to treat the autoimmune disease systemic lupus erythematosus (SLE) in the EU for more than 10 years.

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

FDA approves AZ's anifrolumab, ending 10-year lupus drug dro...

AstraZeneca has completed the resurrection of its anifrolumab drug for systemic lupus erythematosus (SLE) after claiming FDA approval for the drug as an add-on therapy for adults with the a

AZ's bid for Fasenra approval in COPD falls short

AZ's lupus drug Saphnelo cleared in EU, challenging GSK's Be...

FDA approves AZ's anifrolumab, ending 10-year lupus drug dro...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks